These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18637501)

  • 61. Emerging concepts in cytomegalovirus infection following hematopoietic stem cell transplantation.
    Camargo JF; Komanduri KV
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):233-238. PubMed ID: 28641094
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.
    Ljungman P; Boeckh M; Hirsch HH; Josephson F; Lundgren J; Nichols G; Pikis A; Razonable RR; Miller V; Griffiths PD;
    Clin Infect Dis; 2017 Jan; 64(1):87-91. PubMed ID: 27682069
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The pathogenesis of human cytomegalovirus.
    Griffiths P; Baraniak I; Reeves M
    J Pathol; 2015 Jan; 235(2):288-97. PubMed ID: 25205255
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients' sera.
    Gomes AC; Baraniak IA; McIntosh MR; Sodi I; Langstone T; Siddiqui S; Atkinson C; McLean GR; Griffiths PD; Reeves MB
    J Gen Virol; 2023 Jun; 104(6):. PubMed ID: 37310000
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of Cytomegalovirus on the Immune System: Implications for Aging and Mental Health.
    Ford BN; Savitz J
    Curr Top Behav Neurosci; 2023; 61():181-214. PubMed ID: 35871707
    [TBL] [Abstract][Full Text] [Related]  

  • 66. How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19.
    Müller L; Di Benedetto S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830421
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.
    Baraniak I; Kropff B; Ambrose L; McIntosh M; McLean GR; Pichon S; Atkinson C; Milne RSB; Mach M; Griffiths PD; Reeves MB
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6273-6278. PubMed ID: 29686064
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Positively Selected Sites at HCMV gB Furin Processing Region and Their Effects in Cleavage Efficiency.
    Stangherlin LM; de Paula FN; Icimoto MY; Ruiz LGP; Nogueira ML; Braz ASK; Juliano L; da Silva MCC
    Front Microbiol; 2017; 8():934. PubMed ID: 28588572
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytomegalovirus Vaccines: Current Status and Future Prospects.
    Anderholm KM; Bierle CJ; Schleiss MR
    Drugs; 2016 Nov; 76(17):1625-1645. PubMed ID: 27882457
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Microtubule Inhibitor Podofilox Inhibits an Early Entry Step of Human Cytomegalovirus.
    Cohen T; Schwarz TM; Vigant F; Gardner TJ; Hernandez RE; Lee B; Tortorella D
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27783035
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Virus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies.
    Yue C; Kang Z; Ai K; Xu D; Wu J; Pan Y; Yan J; Liu M; Liu Q
    Oncotarget; 2016 Aug; 7(33):53930-53940. PubMed ID: 27340772
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Human Cytomegalovirus UL116 Gene Encodes an Envelope Glycoprotein Forming a Complex with gH Independently from gL.
    Caló S; Cortese M; Ciferri C; Bruno L; Gerrein R; Benucci B; Monda G; Gentile M; Kessler T; Uematsu Y; Maione D; Lilja AE; Carfí A; Merola M
    J Virol; 2016 May; 90(10):4926-38. PubMed ID: 26937030
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The life cycle and pathogenesis of human cytomegalovirus infection: lessons from proteomics.
    Jean Beltran PM; Cristea IM
    Expert Rev Proteomics; 2014 Dec; 11(6):697-711. PubMed ID: 25327590
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.
    Amsler L; Verweij M; DeFilippis VR
    J Mol Biol; 2013 Dec; 425(24):4857-71. PubMed ID: 24013068
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry.
    Lin LT; Chen TY; Lin SC; Chung CY; Lin TC; Wang GH; Anderson R; Lin CC; Richardson CD
    BMC Microbiol; 2013 Aug; 13():187. PubMed ID: 23924316
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A peptide inhibitor of cytomegalovirus infection from human hemofiltrate.
    Borst EM; Ständker L; Wagner K; Schulz TF; Forssmann WG; Messerle M
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4751-60. PubMed ID: 23856778
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Discovery of cellular proteins required for the early steps of HCV infection using integrative genomics.
    Park JH; Park S; Yang JS; Kwon OS; Kim S; Jang SK
    PLoS One; 2013; 8(4):e60333. PubMed ID: 23593195
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The immune response to human CMV.
    La Rosa C; Diamond DJ
    Future Virol; 2012 Mar; 7(3):279-293. PubMed ID: 23308079
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An endothelial cell-specific requirement for the UL133-UL138 locus of human cytomegalovirus for efficient virus maturation.
    Bughio F; Elliott DA; Goodrum F
    J Virol; 2013 Mar; 87(6):3062-75. PubMed ID: 23283945
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship.
    Rossini G; Cerboni C; Santoni A; Landini MP; Landolfo S; Gatti D; Gribaudo G; Varani S
    Mediators Inflamm; 2012; 2012():607276. PubMed ID: 22701276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.